Phase I dose escalation, pharmacokinetic and pharmacodynamic study of naptumomab estafenatox alone in patients with advanced cancer and with docetaxel in patients with advanced non-small-cell lung cancer
Borghaei, Hossein Alpaugh, Katherine Hedlund, Gunnar Forsberg, Goran Langer, Corey J Rogatko, Andre Hawkins, Robert E Dueland Svein Lassen, Ulrik Cohen, Roger B
Borghaei, Hossein
Alpaugh, Katherine
Hedlund, Gunnar
Forsberg, Goran
Langer, Corey J
Rogatko, Andre
Hawkins, Robert E
Dueland Svein
Lassen, Ulrik
Cohen, Roger B
Citations
Altmetric:
Abstract
Description
Date
2009
Publisher
Keywords
Advanced Cancer
Non-Small-Cell Lung Cancer
ABR-217620
Dose Escalation
Non-Small-Cell Lung Cancer
ABR-217620
Dose Escalation
Type
Article
Citation
Phase I dose escalation, pharmacokinetic and pharmacodynamic study of naptumomab estafenatox alone in patients with advanced cancer and with docetaxel in patients with advanced non-small-cell lung cancer. 2009, 27(25): 4116-4123 J Clin Onc